A nod to sexual activity: it is possible to have a normal sex life.

It should be considered as any physical activity having the concern to listen to the messages of your body (breathing difficulties, chest pain).

Studies from the early 2000s: COMPANION (2004), SCD-HeFT (2005); MADIT-CRT (2009) led to a shift of perspective from drugs to implantable cardiac devices, defibrillators and biventricular pacemakers that allowed further therapeutic progress.

If cardiac dysfunction recognizes an ischemic origin, angioplasty can be done.

This intervention restores the coronary flow in an obstructed vessel or by shattering the plaque that occludes it or, in the presence of an obstruction due to a vascular constriction, by placing in situ a device (stent) which, adhering to the internal wall of the vessel, resolves and prevents the shrinkage of the same.

  1. Medicated stents can be implanted which gradually release a drug that reduces the risk of restenosis.
  2. In case of more serious coronary artery disease, BPO (coronary artery bypass grafting) can be used. Severe valve dysfunctions require valve repair or replacement.

The artificial heart is intended as both an additional and a replacement pump. Not only, therefore, as a bridge waiting for the transplant, but also as a definitive therapy. The recovery of the cardiac contractile function is aimed at improving the patient’s quality of life and also reducing the number of hospitalizations.

Finally, heart transplantation is the gold standard for the treatment of severely refractory or terminal heart failure.A latest PARADIGM HF study (2014) unfortunately reminds us that the mortality of decompensated patients is still high (20% at two years) and shows us that there is still a long way to go.

  • On the other hand, we can say that the evolution of heart failure therapy has been gradual but, continuously, improving and we can only be admired on the path we have traveled.
  • The information on the site must serve to improve, and not replace, the doctor-patient relationship. In case of ailments and / or illnesses, contact your GP or a specialist.

Cardiovascular diseases, use of aspirin in prevention.

What the updated guidelines say

The US Preventive Services Task Force has updated guidelines on the use of low-dose aspirin in the prevention of cardiovascular (CV) risk.For experts, people 60 or older shouldn’t start taking it as a primary prevention of CV disease.

In the case of individuals between 40 and 59 years of age, however, the use of the drug can be considered in the presence of a 10-year risk of CV disease of at least 10%, but the final decision must be assessed individually. Indeed, the net benefit is limited in this age group. However, people with no increased risk of bleeding will benefit the most.

Cardiovascular diseases, use of aspirin in prevention.It should be noted that the recommendations, available on JAMA, apply only to individuals who have no history or signs or symptoms of CV disease or a condition for which aspirin is indicated.

“People who currently take aspirin and have doubts about why they do it, or whether they should continue or stop, should discuss it with their doctor,” the experts write, noting how age, CV risk and bleeding levels, preferences and motivations are the factors that doctors need to keep in mind.

As explained by group vice chair Michael Barry, of Harvard Medical School in Boston, aspirin is just one of the tools with which CV risk can be lowered. “People can significantly reduce their risk in many other ways, such as exercising, eating a healthy diet, controlling blood pressure and diabetes, and taking statins if they have an increased CV risk,” he said.